Get started
Author

Shahd H. M. Hamid

Observed names: Hamid, Shahd, S Hamid, Shahd H M Hamid, Shahd H. Hamid, Shahd HM Hamid, Shahd Hamid, Shahd Hassan Mahmoud Hamid
Observed institutions: University of Liverpool, University of Khartoum, King's College London, University of Cambridge, Royal Victoria Infirmary, Walton Centre, University of Oxford, Hamad General Hospital, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London, Hamad Medical Corporation
ORCID: 0000-0001-9714-9642
Observed ORCID: 0000-0001-9714-9642
OpenAlex ID: A5079507221
Clinical presentation and prognosis in MOG-antibody disease: a UK study
2017 · Maciej Jurynczyk, Silvia Messina, et al. · Brain · 742
What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
2017 · Shahd H. M. Hamid, Daniel Whittam, et al. · Journal of Neurology · 222
PDF
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
2019 · Jacqueline Palace, Dan-Yu Lin, et al. · Brain · 217
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
2017 · Shahd H. M. Hamid, Dan Whittam, et al. · JAMA Neurology · 215
PDF
Cognitive and psychiatric comorbidities in neuromyelitis optica
2015 · Perry Moore, Abigail Methley, et al. · Journal of the Neurological Sciences · 81
The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates
2016 · Shahd HM Hamid, Liene Elsone, et al. · Multiple Sclerosis Journal · 68
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
2023 · Mirasol Forcadela, Chiara Rocchi, et al. · Neurology Neuroimmunology & Neuroinflammation · 55
PDF
Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis
2016 · George Tackley, Domizia Vecchio, et al. · Journal of Neurology Neurosurgery & Psychiatry · 47
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
2023 · Benedict D. Michael, Cordelia Dunai, et al. · Nature Communications · 46
PDF
Contribution of Noncommunicable Diseases to Medical Admissions of Elderly Adults in Africa: A Prospective, Cross‐Sectional Study in Nigeria, Sudan, and Tanzania
2014 · Rufus O. Akinyemi, Isameldin M. H. Izzeldin, et al. · Journal of the American Geriatrics Society · 43
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder
2015 · Kerry Mutch, Sizheng Zhao, et al. · Multiple Sclerosis and Related Disorders · 42
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
2020 · Jacqueline Palace, Dean M. Wingerchuk, et al. · Multiple Sclerosis and Related Disorders · 41
PDF
What’s new in neuromyelitis optica? A short review for the clinical neurologist
2017 · Daniel Whittam, Martin Wilson, et al. · Journal of Neurology · 38
Neuromyelitis optica in patients with increased interferon alpha concentrations
2019 · Jac Williams, Sarah McGlasson, et al. · The Lancet Neurology · 16
PDF
Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines
2016 · P Moore, C Jackson, et al. · BMJ Open · 13
PDF
If they are OK, we are OK: the experience of partners living with neuromyelitis optica
2016 · Kerry Mutch, Abigail Methley, et al. · Disability and Rehabilitation · 11
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study
2024 · Daniel Lordelo San Martin, Thiago Gonçalves Fukuda, et al. · Multiple Sclerosis and Related Disorders · 9
Ethnic Differences in Dystonia Prevalence and Phenotype
2022 · Eoin Mulroy, Antonella Macerollo, et al. · Movement Disorders · 8
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis
2024 · Chiara Rocchi, Mirasol Forcadela, et al. · Multiple Sclerosis Journal · 6
PDF
Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS—A multicentre case–control study
2025 · Rajish S. K. Shil, Adam Seed, et al. · Scientific Reports · 5
For how long should patients with FCD be followed up?
2019 · Shahd Hamid, Andrew J Larner · Progress in Neurology and Psychiatry · 5
PDF
Tonic spasms and short myelitis in an elderly woman—unique onset of neuromyelitis optica
2015 · Shahd Hamid, Liene Elsone, et al. · Practical Neurology · 3
Do we still need OCBs in MS diagnosis and how many?
2023 · Mirasol Forcadela, Katherine Birch, et al. · Multiple Sclerosis and Related Disorders · 2
Comparative neurologic toxicity profiles of chemotherapy versus immune checkpoint inhibitors in melanoma: a propensity score-matched analysis
2026 · Majd A. Abualrob, Sami Alshehab, et al. · Supportive Care in Cancer · 1
PDF
Opposing Influences of Optic Neuritis and Transverse Myelitis on the Future Location of Relapses in MOG Antibody–Associated Disease
2025 · Daniel Lordelo San Martin, Marcos Baruch Portela Filho, et al. · Brain and Behavior · 1
Works count: 48
Citation count: 1,940
H-index: 14
I10-index: 16
Year
Topic
Type